Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
medicaid
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
national
aimmune therapeutics
alex azar
allergy
alliance for aging research
american society of clinical oncology (asco)
amgen
anaphylaxis
andrew oxtoby
anti-inflammatory drugs
arcturus therapeutics
What
drug
3
×
administration
agency
ahead
aimmune
allergy
ambien
american
angry
annual
anti
approval
approved
asco
attendees
attention
awarded
benefited
biotech
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
days
despite
developed
expanding
fda
fear
focus
friday
home
immunotherapy
industry
key
kicks
Language
unset
Current search:
medicaid
×
drug
×
fda
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
